The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 27, 2022

Filed:

Apr. 05, 2008
Applicants:

Pamela A. Silver, Cambridge, MA (US);

Pablo Gabriel Cironi Lopez, Madrid, ES;

David G. Miguez, Barcelona, ES;

Inventors:

Pamela A. Silver, Cambridge, MA (US);

Pablo Gabriel Cironi Lopez, Madrid, ES;

David G. Miguez, Barcelona, ES;

Assignee:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 19/00 (2006.01); C07K 14/52 (2006.01); C07K 16/28 (2006.01); C07K 14/485 (2006.01); C07K 14/525 (2006.01); C07K 14/56 (2006.01); C07K 14/575 (2006.01); C07K 16/30 (2006.01); A61K 47/64 (2017.01); A61K 47/68 (2017.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2863 (2013.01); A61K 47/642 (2017.08); A61K 47/6425 (2017.08); A61K 47/6813 (2017.08); A61K 47/6849 (2017.08); A61K 47/6853 (2017.08); C07K 14/485 (2013.01); C07K 14/525 (2013.01); C07K 14/56 (2013.01); C07K 14/5759 (2013.01); C07K 16/2896 (2013.01); C07K 16/3007 (2013.01); A61K 38/00 (2013.01); C07K 2317/34 (2013.01); C07K 2317/622 (2013.01); C07K 2317/76 (2013.01); C07K 2319/30 (2013.01); C07K 2319/33 (2013.01); C07K 2319/74 (2013.01);
Abstract

Aspects of the invention provide methods for harnessing the potential of proteins that occur naturally (e.g., in humans) and that have serious but finite toxicity. Aspects of the invention relate to a quantitative systems-biological and structural approach to design a class Mof chimeric proteins that avoid the toxicity of protein drugs while retaining their desired activities. In particular, chimeric proteins containing a variant form of a natural protein fused to a targeting moiety may be administered to a subject to target a signal (e.g., induction of apoptosis) to particular cells without having a generalized toxic effect.


Find Patent Forward Citations

Loading…